388 related articles for article (PubMed ID: 11821471)
41. The treatment of cranial germ cell tumours.
Brandes AA; Pasetto LM; Monfardini S
Cancer Treat Rev; 2000 Aug; 26(4):233-42. PubMed ID: 10913379
[TBL] [Abstract][Full Text] [Related]
42. Germ cell tumours of the central nervous system: treatment consideration based on 111 cases and their long-term clinical outcomes.
Sawamura Y; Ikeda J; Shirato H; Tada M; Abe H
Eur J Cancer; 1998 Jan; 34(1):104-10. PubMed ID: 9624246
[TBL] [Abstract][Full Text] [Related]
43. Salvage radiation therapy for intracranial germinoma recurring after primary chemotherapy.
Shibamoto Y; Sasai K; Kokubo M; Hiraoka M
J Neurooncol; 1999 Sep; 44(2):181-5. PubMed ID: 10619503
[TBL] [Abstract][Full Text] [Related]
44. Upfront chemotherapy followed by response adaptive radiotherapy for intracranial germinoma: Prospective multicenter cohort study.
Lee DS; Lim DH; Kim IH; Kim JY; Han JW; Yoo KH; Park KD; Park HJ; Chung NG; Suh CO; Kim DS
Radiother Oncol; 2019 Sep; 138():180-186. PubMed ID: 31319280
[TBL] [Abstract][Full Text] [Related]
45. Intensive induction-sequential chemotherapy with BOP/VIP-B compared with treatment with BEP/EP for poor-prognosis metastatic nonseminomatous germ cell tumor: a Randomized Medical Research Council/European Organization for Research and Treatment of Cancer study.
Kaye SB; Mead GM; Fossa S; Cullen M; deWit R; Bodrogi I; van Groeningen C; Sylvester R; Collette L; Stenning S; De Prijck L; Lallemand E; deMulder P
J Clin Oncol; 1998 Feb; 16(2):692-701. PubMed ID: 9469359
[TBL] [Abstract][Full Text] [Related]
46. Neoadjuvant chemotherapy for newly diagnosed germ-cell tumors of the central nervous system.
Allen JC; Kim JH; Packer RJ
J Neurosurg; 1987 Jul; 67(1):65-70. PubMed ID: 2439668
[TBL] [Abstract][Full Text] [Related]
47. Radiation therapy for relapsed CNS germinoma after primary chemotherapy.
Merchant TE; Davis BJ; Sheldon JM; Leibel SA
J Clin Oncol; 1998 Jan; 16(1):204-9. PubMed ID: 9440744
[TBL] [Abstract][Full Text] [Related]
48. Craniospinal radiation in the treatment of biopsy-proven intracranial germinomas: twenty-five years' experience in a single center.
Maity A; Shu HK; Janss A; Belasco JB; Rorke L; Phillips PC; Sutton LN; Goldwein JW
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1165-70. PubMed ID: 15001260
[TBL] [Abstract][Full Text] [Related]
49. Retrospective multi-institutional study of radiotherapy for intracranial non-germinomatous germ cell tumors.
Aoyama H; Shirato H; Yoshida H; Hareyama M; Nishio M; Yanagisawa T; Kakuto Y; Watarai J; Inakoshi H; Miyasaka K
Radiother Oncol; 1998 Oct; 49(1):55-9. PubMed ID: 9886698
[TBL] [Abstract][Full Text] [Related]
50. Treatment results and prognostic factors for intracranial nongerminomatous germ cell tumors: single institute experience.
Lai IC; Wong TT; Shiau CY; Hu YW; Ho DM; Chang KP; Guo WY; Chang FC; Liang ML; Lee YY; Chen HH; Yen SH; Chen YW
Childs Nerv Syst; 2015 May; 31(5):683-91. PubMed ID: 25749900
[TBL] [Abstract][Full Text] [Related]
51. Long-term follow-up of a phase III study of three versus four cycles of bleomycin, etoposide, and cisplatin in favorable-prognosis germ-cell tumors: the Indian University experience.
Saxman SB; Finch D; Gonin R; Einhorn LH
J Clin Oncol; 1998 Feb; 16(2):702-6. PubMed ID: 9469360
[TBL] [Abstract][Full Text] [Related]
52. Acute myelogenous leukemia after treatment for malignant germ cell tumors in children.
Schneider DT; Hilgenfeld E; Schwabe D; Behnisch W; Zoubek A; Wessalowski R; Göbel U
J Clin Oncol; 1999 Oct; 17(10):3226-33. PubMed ID: 10506623
[TBL] [Abstract][Full Text] [Related]
53. Intensive chemotherapy followed by reduced-dose radiotherapy for biopsy-proven CNS germinoma with elevated beta-human chorionic gonadotropin.
Lim DH; Yoo KH; Lee NH; Lee SH; Sung KW; Koo HH; Kim JH; Suh YL; Joung YS; Shin HJ
J Neurooncol; 2014 Apr; 117(2):279-85. PubMed ID: 24488445
[TBL] [Abstract][Full Text] [Related]
54. Relapse-free and overall survival in patients with pathologic stage II nonseminomatous germ cell cancer treated with etoposide and cisplatin adjuvant chemotherapy.
Kondagunta GV; Sheinfeld J; Mazumdar M; Mariani TV; Bajorin D; Bacik J; Bosl GJ; Motzer RJ
J Clin Oncol; 2004 Feb; 22(3):464-7. PubMed ID: 14752068
[TBL] [Abstract][Full Text] [Related]
55. Low-dose craniospinal irradiation and ifosfamide, cisplatin and etoposide for non-metastatic embryonal tumors in the central nervous system.
Yasuda K; Taguchi H; Sawamura Y; Ikeda J; Aoyama H; Fujieda K; Ishii N; Kashiwamura M; Iwasaki Y; Shirato H
Jpn J Clin Oncol; 2008 Jul; 38(7):486-92. PubMed ID: 18573848
[TBL] [Abstract][Full Text] [Related]
56. Intracranial germinoma: radiation therapy with tumor volume-based dose selection.
Shibamoto Y; Sasai K; Oya N; Hiraoka M
Radiology; 2001 Feb; 218(2):452-6. PubMed ID: 11161161
[TBL] [Abstract][Full Text] [Related]
57. Treatment outcome of radiation therapy for intracranial germinoma: adaptive radiation field in relation to response to chemotherapy.
Joo JH; Park JH; Ra YS; Im HJ; Koh KN; Khang SK; Do Ahn S
Anticancer Res; 2014 Oct; 34(10):5715-21. PubMed ID: 25275079
[TBL] [Abstract][Full Text] [Related]
58. Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors.
Kondagunta GV; Bacik J; Donadio A; Bajorin D; Marion S; Sheinfeld J; Bosl GJ; Motzer RJ
J Clin Oncol; 2005 Sep; 23(27):6549-55. PubMed ID: 16170162
[TBL] [Abstract][Full Text] [Related]
59. Radiation therapy for intracranial germ cell tumors.
Haas-Kogan DA; Missett BT; Wara WM; Donaldson SS; Lamborn KR; Prados MD; Fisher PG; Huhn SL; Fisch BM; Berger MS; Le QT
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):511-8. PubMed ID: 12738328
[TBL] [Abstract][Full Text] [Related]
60. Thiotepa-based high-dose chemotherapy with autologous stem-cell rescue in patients with recurrent or progressive CNS germ cell tumors.
Modak S; Gardner S; Dunkel IJ; Balmaceda C; Rosenblum MK; Miller DC; Halpern S; Finlay JL
J Clin Oncol; 2004 May; 22(10):1934-43. PubMed ID: 15143087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
